SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-16-085249
Filing Date
2016-03-01
Accepted
2016-03-01 12:13:59
Documents
1
Group Members
FRED KNOLLGAKASA HOLDINGS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G v433117_sc13g.htm SC 13G 91583
  Complete submission text file 0001144204-16-085249.txt   93470
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Subject) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50777 | Film No.: 161472172
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 EAST 44TH STREET 12TH FLOOR NEW YORK NY 10017
Business Address 5 EAST 44TH STREET 12TH FLOOR NEW YORK NY 10017 212-808-7474
Knoll Capital Management, LP (Filed by) CIK: 0001325083 (see all company filings)

IRS No.: 133476926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G